XML 18 R5.htm IDEA: XBRL DOCUMENT v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE NONCONTROLLING INTERESTS AND EQUITY (Unaudited) - USD ($)
$ in Millions
Total
Common Stock
Additional paid-in capital
Series A preferred stock
Retained earnings (accumulated deficit)
Accumulated other comprehensive income (loss)
Noncontrolling interests
Increase (Decrease) in Temporary Equity [Roll Forward]              
Redeemable noncontrolling interest adjustment $ 4            
Accretion of redeemable noncontrolling interests 9            
Balance, beginning of period (in shares) at Dec. 31, 2022   160,000,000          
Balance, beginning of period at Dec. 31, 2022 5,809 $ 2 $ 5,915 $ 1 $ (713) $ (37) $ 641
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Common stock issuances, net of equity raise costs (in shares)   2,000,000          
Common stock issuances, net of equity raise costs 140   140        
Contributions from noncontrolling interests 5   3       2
Distributions (12)           (12)
Stock-based compensation 5   3       2
Other comprehensive income (loss) (9)         (8) (1)
Redemption of common stock (3)   (3)        
Redemption of units issued as stock compensation (10)   (9)       (1)
Redeemable noncontrolling interest adjustment (4)   (4)        
Accretion of redeemable noncontrolling interests (9)   (9)        
Net income (loss) 19       18   1
Reallocation of noncontrolling interests     (21)     2 19
Balance, end of period (in shares) at Mar. 31, 2023   162,000,000          
Balance, end of period at Mar. 31, 2023 5,931 $ 2 6,015 1 (695) (43) 651
Balance, beginning of period (in shares) at Dec. 31, 2022   160,000,000          
Balance, beginning of period at Dec. 31, 2022 5,809 $ 2 5,915 1 (713) (37) 641
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Redemption of common stock (3)            
Net income (loss) 11            
Balance, end of period (in shares) at Jun. 30, 2023   162,000,000          
Balance, end of period at Jun. 30, 2023 5,949 $ 2 6,001 1 (700) (8) 653
Increase (Decrease) in Temporary Equity [Roll Forward]              
Accretion of redeemable noncontrolling interests 9            
Balance, beginning of period (in shares) at Mar. 31, 2023   162,000,000          
Balance, beginning of period at Mar. 31, 2023 5,931 $ 2 6,015 1 (695) (43) 651
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Common stock issuances, net of equity raise costs 2   2        
Distributions (12)           (12)
Stock-based compensation 6   4       2
Other comprehensive income (loss) 39         35 4
Accretion of redeemable noncontrolling interests (9)   (9)        
Net income (loss) (8)       (5)   (3)
Reallocation of noncontrolling interests     (11)       11
Balance, end of period (in shares) at Jun. 30, 2023   162,000,000          
Balance, end of period at Jun. 30, 2023 5,949 $ 2 6,001 1 (700) (8) 653
Balance, beginning of period at Dec. 31, 2023 349            
Increase (Decrease) in Temporary Equity [Roll Forward]              
Distributions (1)            
Redemption of redeemable noncontrolling interests (6)            
Expiration of redemption option (92)            
Accretion of redeemable noncontrolling interests 6            
Balance, end of period at Mar. 31, 2024 $ 256            
Balance, beginning of period (in shares) at Dec. 31, 2023 162,017,515 162,000,000          
Balance, beginning of period at Dec. 31, 2023 $ 5,673 $ 2 5,961 1 (879) (34) 622
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Distributions (12)           (12)
Stock-based compensation 5   3       2
Other comprehensive income (loss) (71)         (63) (8)
Redemption of common stock (25)   (25)        
Expiration of redemption option 92   65       27
Accretion of redeemable noncontrolling interests (6)   (6)        
Net income (loss) (48)       (40)   (8)
Reallocation of noncontrolling interests     (7)       7
Balance, end of period (in shares) at Mar. 31, 2024   162,000,000          
Balance, end of period at Mar. 31, 2024 5,608 $ 2 5,991 1 (919) (97) 630
Balance, beginning of period at Dec. 31, 2023 349            
Balance, end of period at Jun. 30, 2024 $ 262            
Balance, beginning of period (in shares) at Dec. 31, 2023 162,017,515 162,000,000          
Balance, beginning of period at Dec. 31, 2023 $ 5,673 $ 2 5,961 1 (879) (34) 622
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Redemption of common stock (25)            
Net income (loss) $ (128)            
Balance, end of period (in shares) at Jun. 30, 2024 161,749,791 162,000,000          
Balance, end of period at Jun. 30, 2024 $ 5,492 $ 2 5,981 1 (987) (119) 614
Balance, beginning of period at Mar. 31, 2024 256            
Increase (Decrease) in Temporary Equity [Roll Forward]              
Redeemable noncontrolling interest adjustment 4            
Accretion of redeemable noncontrolling interests 2            
Balance, end of period at Jun. 30, 2024 262            
Balance, beginning of period (in shares) at Mar. 31, 2024   162,000,000          
Balance, beginning of period at Mar. 31, 2024 5,608 $ 2 5,991 1 (919) (97) 630
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Common stock issuances, net of equity raise costs 1   1        
Distributions (12)           (12)
Stock-based compensation 6   4       2
Other comprehensive income (loss) (25)         (22) (3)
Redeemable noncontrolling interest adjustment (4)   (4)        
Accretion of redeemable noncontrolling interests (2)   (2)        
Net income (loss) $ (80)       (68)   (12)
Reallocation of noncontrolling interests     (9)       9
Balance, end of period (in shares) at Jun. 30, 2024 161,749,791 162,000,000          
Balance, end of period at Jun. 30, 2024 $ 5,492 $ 2 $ 5,981 $ 1 $ (987) $ (119) $ 614